May 10, 2022 · Dual antiplatelet therapy (DAPT) combines aspirin and a P2Y12 inhibitor. It stops platelets from sticking together, decreasing the risk of blood clots, heart attack and stroke.

The DAPT Score predicts which patients will benefit from prolonged DAPT after coronary stent placement.

Jun 2, 2025 · Clopidogrel-based DAPT is recommended for patients with STEMI who receive fibrinolytic therapy. In patients with NSTEMI who undergo medical therapy alone, the guideline gives a Class 1 …

You may be prescribed DAPT if you had a heart attack, were treated with stents in your coronary arteries or had coronary artery bypass graft (CABG) surgery. DAPT decreases the risk of future …

Dec 15, 2023 · Options for long-term antiplatelet therapy include dual antiplatelet therapy (DAPT; aspirin plus platelet P2Y 12 receptor blocker) or single antiplatelet therapy (aspirin or P2Y12 receptor blocker).

Dec 27, 2023 · Dual antiplatelet treatment has been shown to lower the risk of recurrent stroke as compared with aspirin alone when treatment is initiated early (≤24 hours) after an acute mild stroke.

The scope of the update is limited to the duration of dual antiplatelet therapy, as well as the effectiveness of DAPT compared to aspirin alone in patients with coronary artery disease.

Aug 1, 2023 · Dual antiplatelet therapy (DAPT) is the mainstay treatment following percutaneous coronary intervention (PCI) with drug-eluting stents (DES) to reduce stent thrombosis and target …

Dual action antiplatelet therapy (DAPT) is a treatment that uses two medicines to prevent dangerous blood clots. These medicines target different stages of the blood clotting process.

Dec 13, 2022 · Dual antiplatelet therapy (DAPT) is used to help prevent blood clots following a stroke or heart attack and for other conditions that may cause blood clots.